Business Standard

Sun Pharma gains on acquisition of URL generic biz

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco.

Related News

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of pharma through its subsidiary for an undisclosed amount.

“Caraco Pharmaceutical Laboratories, wholly-owned subsidiary of the company, has entered into a definitive agreement with Pharmaceuticals U.S.A., Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc. generic business,” said in a statement.

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, it added.

The stock opened at Rs 727 and hit a high of Rs 733 on the NSE. A combined 138,547 shares have changed hands on the counter in morning deals.

Read more on:   
|
|

Read More

Two entities fail to make prima facie case to revoke ban: Sebi

The Securities and Exchange Board of India (Sebi) today said the restraining order on two entities, related to plunge in some mid-cap stocks in July, ...

Quick Links

 

Market News

Sensex to hit 32,980 by December 2015: Reuters Poll

Inplementation of fast reforms and FM's assurance on GST from 2016 makes analysts feel bullish

Market falls for fifth session

In a volatile session ahead of US Fed announcement, Sensex recovers 240 pts from day's low

Sugar price hits three-year low on supply glut

Isma estimates the total output this season till December 15 at 4.23 mt against 2.9 mt last year; number of operational mills has risen this

Maharashtra cooperative sugar sector demands bailout package from Centre

Say cane payment to farmers at set price impossible without support price of Rs 700 a tonne, other help

Brent drops below $60 as OPEC, Russia keep output steady amid glut

US crude oil traded 20 cents higher at 56.13, after touching its lowest since May 2009 at $53.60 on Tuesday

Back to Top